Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Mastering Urine Microscopy

On-demand Webinar: Microscopy in urinalysis.

Higher throughput in less time

Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Säkerhetsbrist i svensk programvara för bröstcancerscreening – kvinna avled

En brist i Sectras programvara ledde till att en kvinna med bröstcancer fick ett felaktigt besked. Hon avled senare. Programmet används i 20 av 21 regioner i Sv...

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Rosling ger namn åt nytt folkhälsocenter i USA

Roslings föreläsningar och TED talks har upplyst miljontals människor om folkhälsan i världen. Nu hedras hans minne med ett nytt folkhälsocenter på University o...

Här är topp fem dyraste läkemedlen 2025

Nya avancerade terapiläkemedel når marknaden, men prislapparna är höga. På årets lista över de dyraste läkemedlen i USA finns en gemensam nämnare: alla är gente...

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

Amrop Malmö AB

New issue of Life Science Sweden!

The international issue of Life Science Sweden has been sent to press.

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

1 500 tjänster bort från Bayer – hittills

Över 1 500 tjänster har försvunnit på kemi- och läkemedelskoncernen Bayer bara under det första kvartalet och merparten av dem är chefstjänster, enligt företagets ledning.

Nordic Regulatory experts: Improving biotech chances of Succ

Why is it that so many biotech companies fail? And what are the tools needed to change that fact?

Try arivis for free

30-day free trial offers a number of benefits.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Uppgifter: Sanofi tar in bud på konsumenthälsodivision

Den franska läkemedelsjätten Sanofi ska enligt uppgifter ha bett om initiala bud för sin konsumenthälsoverksamhet, som är värderad till runt 20 miljarder dollar.

Del 5 i Advance serien: Projektsupport & Driftsättning

Spirax Sarco säkerställer att alla system och komponenter levereras i full överensstämmelse med kundens operativa krav, från teknisk design och installation til...

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...